other material
confidence high
sentiment neutral
materiality 0.50
Aptevo raises $2.0M in registered direct offering at $0.862/share
Aptevo Therapeutics Inc.
- Sold 2,324,000 shares at $0.862 each, gross proceeds ~$2.0M; net ~$1.8M after fees.
- Roth Capital Partners acted as exclusive placement agent, receiving 7.0% cash fee.
- Proceeds to fund clinical programs, working capital, and general corporate purposes.
- Offering closed April 22, 2025; 5-day lockup on further equity issuance following close.